Published April 17, 2018 | Version v1
Patent Open

Methods and compositions related to T-cell activity

Description

Embodiments concern methods and composition related to anergic T-cells in patients, such as cancer patients. T cell anergy is a hyporesponsive state induced by TCR engagement in the absence of costimulation (Schwartz, 2003). Anergy induction was initially observed in vitro using chemically-fixed antigen presenting cells (APCs). Subsequently, it was found that anergy could be induced by immobilized anti-CD3 mAb or calcium ionophores (such as ionomycin) in vitro, and by superantigen and soluble antigenic peptide in vivo. Indirect evidence has suggested that T cell dysfunction in the tumor microenvironment and establishment of transplant tolerance is partially due to T cell anergy (Gajewski et al., 2011).

Files

US9944992.pdf

Files (3.9 MB)

Name Size Download all
md5:b7ed1291463ff23c0f7f319755b06ff2
3.9 MB Preview Download

Additional details

Identifiers

Patent number
US 9944992 B2
Patent application number
US 201414777123 A
Other
oai:uchicago.tind.io:8190

Dates

Patent filed
2014-03-14

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Immunology, Medicine